Order Book Or Contract Wins
What: Order Book Value: Highest-ever
“Highest-ever order book and diversified business mix provide clear earnings visibility for H2 FY26 and beyond.”
In , Cupid Ltd (Contraceptives/Protectives) is outperforming Nifty 500 with +59.3% relative strength. Fundamentals: Average. On a 6-week streak.
Weekly presence in the outperformers list. Green = beating Nifty 500 by 10%+ that week.
Based on Q4 FY26 earnings • Updated Apr 18, 2026
What: Order Book Value: Highest-ever
“Highest-ever order book and diversified business mix provide clear earnings visibility for H2 FY26 and beyond.”
What: South Africa Program: $12.98 Mn annual revenue
Impact: ~₹115 Cr per year
“Secured Allocation Under South Africa’s 5-year (2025–2030) National Female & Male Condoms Program... Total $ 12.98 Mn (~₹115 Cr).”
What: EBITDA Margin: 36.69%
Impact: 1213 bps expansion
“Improved scale and operating leverage supported healthy profitability, despite continued investments in growth.”
What: FMCG SKU Count: Multiple new launches
“New product launches have received encouraging consumer response... FMCG products witnessing improving acceptance in domestic markets.”
What: CE Certifications: Achieved for IVD kits
“CE (EU IVDR) Certifications Achieved... Enables participation in European, African, and Latin American tenders.”
What: Revenue beat of 105.64% Y-o-Y
“Strong revenue growth driven by a record order book, steady export execution, and rising FMCG contribution.”
What: ₹335 Cr → > ₹335 Cr
“We are confident of exceeding our FY26 revenue guidance of ₹335 crore, with net profit expected to exceed ₹100 Cr”
Earnings deceleration risks from management commentary
Trigger: High entry barriers are maintained through these certifications; any lapse would impact tender eligibility.
Management view: Company focuses on certification-led competitive advantage to enable participation in regulated tenders.
Monitor: regulatory
Key quotes from recent conference calls
“We are confident of exceeding our FY26 revenue guidance of ₹335 crore, with net profit expected to exceed ₹100 Cr [Previous Revenue Guidance FY26 guidance]”
“₹ 150 Cr incremental revenue expected in FY27... annual business potential within three years as the ecosystem scales. [Initiative: Style Baazar Strategic Investment]”
“Board has granted in-principle approval to set up a FMCG manufacturing facility in Saudi Arabia which the management is currently exploring. [Initiative: Saudi Arabia FMCG Facility]”
“WHO/UNFPA prequalification and USFDA CE certifications create high entry barriers and enable participation in regulated global tenders. [Risk (regulatory): MEDIUM]”
Headline numbers from the latest earnings call
Revenue
₹104.38 Cr
Why: Strong revenue growth was driven by a record order book, steady export execution, and rising FMCG contribution.
The company achieved its highest-ever quarterly revenue, crossing the ₹100 Cr mark for the first time.
EBITDA
₹34.30 Cr
Why: Improved scale and operating leverage supported healthy profitability despite continued investments in growth.
EBITDA margins expanded significantly from 24.56% in Q3 FY25 to 36.69% in the current quarter.
PAT
₹32.83 Cr
Why: Profitability was bolstered by high-margin female condom sales and increased other income of ₹10.89 Cr.
Net profit margins reached 35.12%, aided by a mix shift toward higher-margin products.
Other Highlights
• Highest-ever order book providing clear revenue visibility for H2 FY26 and beyond.
• Other income rose to ₹10.89 Cr from ₹4.41 Cr in the previous year's quarter.
• Earnings Per Share (EPS) increased to ₹1.22 from ₹0.41 Y-o-Y.
Sub-sector-specific signals from the latest concall — each with management's stated reason for the change
Order Book Value
Highest-ever
Why: Driven by multi-year international contracts and rising FMCG traction.
Female Condom Revenue Share
61%
Why: Mix shift toward higher-margin female condoms in the Brazil and South Africa orders.
Export Revenue %
94%
Why: Dominance of international B2B tender business.
Capacity Utilisation
90%
Why: High demand from international orders.
FMCG Retail Reach
1.50 lakh+
Why: Aggressive expansion of domestic distribution backbone.
Post-expansion Male Condom Capacity
~1.25 Bn
Why: Expansion at Palava facility to support rising volumes.
Post-expansion Female Condom Capacity
~125 Mn
Why: Expansion at Palava facility to support rising volumes.
Rapid IVD Test Kits in Production
15
Why: Scaling up the diagnostics business as a new growth engine.
Forward-looking targets from management for FY26
> ₹335 Cr
Guidance Changes
Revenue: ₹335 Cr → > ₹335 Cr
Revenue, profit and margin growth rates
| Metric | YoY | 3Y CAGR | Trend |
|---|---|---|---|
| Revenue | +104% | +11% | Inflection Up |
| PAT (Net Profit) | +200% | +34% | Inflection Up |
| OPM | 37.0% | +1200 bps | Volatile |
The above analysis is parsed from publicly available earnings call transcripts. This is educational research only — not investment advice. Last updated Apr 18, 2026.
Based on publicly available financial data. This is educational research, not investment advice.
Cupid Ltd's latest quarterly results (Dec 2025) show
Cupid Ltd's profit is growing with an turning around (inflection up) trend.
Cupid Ltd's revenue growth trend is turning around (inflection up).
Cupid Ltd's operating margin is volatile.
Cupid Ltd's long-term compounding rates
Cupid Ltd's earnings growth is turning around (inflection up) with positive momentum on a sequential basis.
Cupid Ltd's trailing twelve month (TTM) performance
Cupid Ltd appears significantly overvalued based on our fair value analysis.
Cupid Ltd's current PE ratio is 193.0x.
Cupid Ltd's current PE is 193.0x.
Cupid Ltd's price-to-book ratio is 42.3x.
Cupid Ltd is rated Average with a fundamental score of 54.59/100. This score is calculated from objective financial metrics
Cupid Ltd has a debt-to-equity ratio of N/A.
Cupid Ltd's return ratios over recent years
Cupid Ltd's operating cash flow is negative (FY2025).
Cupid Ltd currently does not pay a significant dividend (yield 0.00%).
Cupid Ltd's shareholding pattern (Mar 2026)
Cupid Ltd's promoter holding has increased recently.
Cupid Ltd has been outperforming Nifty 500 for 6 consecutive weeks, indicating building momentum.
Cupid Ltd is an established outperformer with 6 weeks of consecutive Nifty 500 outperformance.
Cupid Ltd has 7 key growth catalysts identified from recent earnings analysis
Cupid Ltd has 1 key risk worth monitoring
In Q4 FY26, Cupid Ltd's management highlighted
Cupid Ltd's management has provided the following forward guidance for FY26
Cupid Ltd's most important sub-sector-specific KPIs from the latest concall
Based on quantitative research signals, here is why Cupid Ltd may be worth studying
Cupid Ltd investment thesis summary:
Cupid Ltd's forward outlook based on current data signals
The above FAQs are generated from publicly available earnings data and conference call transcripts. This is educational research only. Sector Alpha is not SEBI registered and does not provide investment advice.